Chronic Kidney Disease: Clinical Challenges and Management
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 14
Special Issue Editors
Interests: vascular biology; cardiovascular disease; hemodialysis; kidney disease; regenerative medicine
Special Issues, Collections and Topics in MDPI journals
Interests: kidney disease; regenerative medicine; hemodialysis; vascular biology; cardiovascular disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic kidney disease (CKD) is a devastating disease which progresses to end-stage renal disease (ESRD) and has a large impact on prognosis in CKD patients via concomitant atherosclerotic cardiovascular diseases, malnutrition, inflammation, malignancy, etc. Previous large clinical trials have shown that drugs, including angiotensin converting enzyme inhibitors (ACEi), angiotensin type Ⅱ receptor blockers (ARBs), SGLT2 inhibitors, and mineral corticoid receptor antagonists (MRAs), retard the progression of CKD. However, the results are still not optimal, leading to an increase in dialysis patients worldwide. Although interventional treatment could retard the progression of CKD, improvement in kidney function (reverse kidney dysfunction), as the final goal, has not been fully achieved. Regenerative cell therapies or exosome therapies using several cell sources are emerging as new potential strategies. However, there are still challenges for human CKD.
Based on the abovementioned background, we introduce this Special Issue, entitled “Chronic Kidney Disease: Clinical Challenges and Management”, in the Journal of Clinical Medicine. As Guest Editors of this Special Issue, we invite submissions focused on treatment approaches (even if challenging and/or small clinical trials), observational research, and trials conducted by specialists in the fields of nursing, nutrition, rehabilitation, pharmacies, and multidisciplinary team approaches for CKD and comorbid diseases.
Dr. Shuzo Kobayashi
Dr. Takayasu Ohtake
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic kidney disease
- clinical trial
- end-stage renal disease
- kidney dysfunction
- management
- challenge
